Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes
Open Access
- 28 April 2020
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 323 (16), 1565-1573
- https://doi.org/10.1001/jama.2020.3308
Abstract
Quiz Ref ID Epigenetics refers to a process whereby chromatin undergoes chemical modification in response to its environment, affecting transcription. One such modification is acetylation of lysine residues on histone proteins. Bromodomain and extraterminal proteins are a family of epigenetic “readers” that detect and bind to acetylated lysine residues, thereby forming molecular scaffolds between chromatin and transcriptional machinery.1-4 Recruitment of bromodomain and extraterminal proteins may enhance the expression of genes that drive maladaptive responses in atherosclerosis, including inflammation, oxidation, complement activation, and thrombogenesis.5,6Keywords
This publication has 29 references indexed in Scilit:
- RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular diseaseAtherosclerosis, 2016
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 DiabetesThe New England Journal of Medicine, 2015
- Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE TrialAmerican Journal of Cardiovascular Drugs, 2015
- BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histonesNature Structural & Molecular Biology, 2014
- NF-κB Directs Dynamic Super Enhancer Formation in Inflammation and AtherogenesisMolecular Cell, 2014
- Use of Hy's Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver InjuryGastroenterology, 2014
- A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient miceAtherosclerosis, 2014
- Efficacy and Safety of a Novel Oral Inducer of Apolipoprotein A-I Synthesis in Statin-Treated Patients With Stable Coronary Artery Disease: A Randomized Controlled TrialJournal of the American College of Cardiology, 2011
- Relation Between Alkaline Phosphatase, Serum Phosphate, and All-Cause or Cardiovascular MortalityCirculation, 2009
- HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular EventsThe New England Journal of Medicine, 2007